Environmental Services

Assisted living facilities face distinct challenges when it comes to infection prevention and control due to their unique nature.

This guide aims to assist hospitals in identifying and managing sepsis at an earlier stage. ICT interviews 1 of the authors.

Medical facilities must consider stinging pests and the infections that they can cause when maintaining their grounds to protect their patients and staff.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, tuberculosis, and changes in leadership at the CDC and NIAID.

Connecting and networking with colleagues, finding the right resources, and joining key organizations can help you become a better infection preventionist.

The report has brought to attention the increasing danger of bacteria that are resistant to modern medicine. This problem has already reached alarming levels in many areas of the world.

With malaria making headlines, infection prevention specialists and other IPC professionals seek answers. To provide clarity, ICT® has consulted with 2 experts in the field.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending July 30, 2023.

Choosing the correct disinfectant can be difficult. This expert explains how to select the proper one.

In this opinion article, the authors discuss their concerns about the recent HICPAC/CDC proposals on infectious diseases.

Mold, a menacing presence that can grow within the walls of your facility, may be lurking and waiting to cause problems. Are you equipped to deal with it?

Have foodborne infections returned to prepandemic levels? What information should infection prevention and control personnel offer to patients and staff to prevent an E coli infection?

As more and more residents in long-term care facilities get Candida auris, infection preventionists must know how to prevent, prepare for, and control a C auris outbreak. An expert explains how.

The recent increase in drug-resistant strains of Candida auris, causing mortality at rates as high as 60%, raises questions regarding the spread of this pathogen as a health care-associated infection, cleaning/disinfecting protocol, and treatment via antifungal drugs.

SSI surveillance tracks infections that occur after surgery in the area where it was performed. How can facilities help prevent these infections?

In this installment of IPC Pros Helping Each Other, how do IPs keep those in their facilities to remember essential infection control practices?

COVID-19, schools, and children are sensitive topics. Some worry about transmission in schools, while others don't see it as a concern. Which is it?

Antibiotics no longer work against many infections due to MDROs, causing more illness and death. What is antimicrobial resistance (AMR) doing to the environment?

Off-site sterilization frees up hospital space for patient care, improving hospital return on investment. This article explains why and how to go about setting up the service.

Legionnaires’ disease is a severe infection and fatal in 10% of cases.

Establishing a permanent system for monitoring the persistence and emergence of dangerous pathogens is necessary, especially COVID-19.

To control C auris, focus on using antibiotics and improving diagnostics. New treatments in development offer hope for better management. This is the fourth and final installment in CDC's interview with the ICT.

To ensure the accuracy of the information concerning Candida auris, Infection Control Today has spoken with 2 medical scientists from the CDC.

Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 30, 2023.

A study published in AJIC describes how one health care system implanted an initiative by their IPs to prevent the health care-acquired infections when COVID-19 loomed over their work.

Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, Marburg Virus Disease, and a 1-hit STI antibiotic plan.

Unlike hospitals, ambulatory settings have traditionally lacked adequate infrastructure and resources to support infection prevention and monitoring.

Numerous pathogen outbreaks have been from the water in medical facilities. So what are the dangers, and what can infection preventionists do to prevent morbidities and mortalities from occurring?

Since the Marburg virus is deadly, what would it be like to work with it in a laboratory setting? And what can be done to protect those who work with patients with Marburg?